TOPIC: Lung Pathology TYPE: Medical Student/Resident Case Reports INTRODUCTION: Pembrolizumab is a humanized monoclonal antibody that targets the programmed cell death-1 receptor in T-cells and becoming more widely utilized. Immunologic checkpoint inhibitors have revolutionized cancer treatment but can be associated with systemic toxicities, including pyrexia, chills, infusion reactions, rarely...